Pub Date : 2026-02-03DOI: 10.1016/j.sempedsurg.2026.151581
Alejandro O Chara, Jessica K Sims, Jonathan Niconchuk, Irving J Zamora
Enhanced recovery after surgery (ERAS) is a multidisciplinary, evidence-based protocol designed to standardize perioperative care, minimize complications, and optimize recovery. While ERAS has demonstrated significant benefits in adult populations, widespread adoption in pediatric surgery remains in progress. One of its central goals is reducing postoperative infections, particularly surgical site infections (SSIs), which represent a common source of morbidity in children. Core ERAS elements-including perioperative nutrition, glycemic control, fluid and temperature management, antibiotic prophylaxis, wound care, device removal, and early mobilization-directly or indirectly influence infection risk. Although pediatric-specific data remain limited, growing evidence supports that ERAS protocols are safe and may reduce SSI incidence. This narrative review outlines how individual ERAS components target SSI prevention, highlights current pediatric evidence, and identifies knowledge gaps where further research is needed to optimize infection prevention strategies for children undergoing surgery.
{"title":"Impact of enhanced recovery after surgery (ERAS) on surgical site infections in pediatric surgery.","authors":"Alejandro O Chara, Jessica K Sims, Jonathan Niconchuk, Irving J Zamora","doi":"10.1016/j.sempedsurg.2026.151581","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151581","url":null,"abstract":"<p><p>Enhanced recovery after surgery (ERAS) is a multidisciplinary, evidence-based protocol designed to standardize perioperative care, minimize complications, and optimize recovery. While ERAS has demonstrated significant benefits in adult populations, widespread adoption in pediatric surgery remains in progress. One of its central goals is reducing postoperative infections, particularly surgical site infections (SSIs), which represent a common source of morbidity in children. Core ERAS elements-including perioperative nutrition, glycemic control, fluid and temperature management, antibiotic prophylaxis, wound care, device removal, and early mobilization-directly or indirectly influence infection risk. Although pediatric-specific data remain limited, growing evidence supports that ERAS protocols are safe and may reduce SSI incidence. This narrative review outlines how individual ERAS components target SSI prevention, highlights current pediatric evidence, and identifies knowledge gaps where further research is needed to optimize infection prevention strategies for children undergoing surgery.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151581"},"PeriodicalIF":2.5,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146144418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1016/j.sempedsurg.2026.151579
Emily M Scire, Dario O Fauza
State-of-the-art minimally invasive in utero interventions involving stem cell, protein, and nucleic acid-based therapies represent a new frontier in medicine, which offers hope for devastating fetal diagnoses and promises the restoration of lifetimes. Yet they also introduce serious concerns regarding health risks posed to mother, fetus, and future generations. Recent international consensus statements provide general guidance for structuring trials to maximize health and minimize the risk of experimental treatments for both a pregnant mother and fetus. This article offers additional ethical guidance for translating interventions from first-in-human studies by focusing on a more holistic and nondirective consent process and encouraging pretrial publication of proposed studies to increase dialogue, fine-tune protocols, and potentially improve access.
{"title":"What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?","authors":"Emily M Scire, Dario O Fauza","doi":"10.1016/j.sempedsurg.2026.151579","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151579","url":null,"abstract":"<p><p>State-of-the-art minimally invasive in utero interventions involving stem cell, protein, and nucleic acid-based therapies represent a new frontier in medicine, which offers hope for devastating fetal diagnoses and promises the restoration of lifetimes. Yet they also introduce serious concerns regarding health risks posed to mother, fetus, and future generations. Recent international consensus statements provide general guidance for structuring trials to maximize health and minimize the risk of experimental treatments for both a pregnant mother and fetus. This article offers additional ethical guidance for translating interventions from first-in-human studies by focusing on a more holistic and nondirective consent process and encouraging pretrial publication of proposed studies to increase dialogue, fine-tune protocols, and potentially improve access.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151579"},"PeriodicalIF":2.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146041894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-10DOI: 10.1016/j.sempedsurg.2026.151580
Emily M Scire, Dario O Fauza
{"title":"From the editor: ethics of pediatric surgical innovation.","authors":"Emily M Scire, Dario O Fauza","doi":"10.1016/j.sempedsurg.2026.151580","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2026.151580","url":null,"abstract":"","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151580"},"PeriodicalIF":2.5,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146020453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-30DOI: 10.1016/j.sempedsurg.2025.151578
Vikas S Gupta, Joseph T Church, Kevin N Johnson
{"title":"Infections in pediatric extracorporeal life support.","authors":"Vikas S Gupta, Joseph T Church, Kevin N Johnson","doi":"10.1016/j.sempedsurg.2025.151578","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151578","url":null,"abstract":"","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151578"},"PeriodicalIF":2.5,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145918868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-24DOI: 10.1016/j.sempedsurg.2025.151577
Andrew P Bain, Jeffrey S Upperman
Surgical site infections (SSIs) remain a significant source of morbidity in pediatric surgery, prolonging hospital stays, increasing readmissions, and driving up healthcare costs. Manual chart reviews and static risk models limit traditional SSI prediction and detection. The rise of artificial intelligence (AI), including machine learning (ML), natural language processing (NLP), and large language models (LLMs), offers a transformative opportunity to enhance prediction and surveillance. This review synthesizes current literature on AI applications in pediatric SSI, emphasizing predictive models built on NSQIP-P data and detection strategies leveraging EHRs and wearable technologies. Despite encouraging retrospective results, real-world adoption remains constrained by poor validation, limited generalizability, and workflow misalignment. Ethical and regulatory concerns, including bias, transparency, and pediatric-specific data limitations, must be addressed to ensure safe, equitable implementation. Thoughtfully developed and deployed, AI-driven tools can transform pediatric surgical care by enabling earlier intervention and improving outcomes.
{"title":"Artificial intelligence for prediction and detection of pediatric surgical site infection.","authors":"Andrew P Bain, Jeffrey S Upperman","doi":"10.1016/j.sempedsurg.2025.151577","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151577","url":null,"abstract":"<p><p>Surgical site infections (SSIs) remain a significant source of morbidity in pediatric surgery, prolonging hospital stays, increasing readmissions, and driving up healthcare costs. Manual chart reviews and static risk models limit traditional SSI prediction and detection. The rise of artificial intelligence (AI), including machine learning (ML), natural language processing (NLP), and large language models (LLMs), offers a transformative opportunity to enhance prediction and surveillance. This review synthesizes current literature on AI applications in pediatric SSI, emphasizing predictive models built on NSQIP-P data and detection strategies leveraging EHRs and wearable technologies. Despite encouraging retrospective results, real-world adoption remains constrained by poor validation, limited generalizability, and workflow misalignment. Ethical and regulatory concerns, including bias, transparency, and pediatric-specific data limitations, must be addressed to ensure safe, equitable implementation. Thoughtfully developed and deployed, AI-driven tools can transform pediatric surgical care by enabling earlier intervention and improving outcomes.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151577"},"PeriodicalIF":2.5,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145897100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-19DOI: 10.1016/j.sempedsurg.2025.151576
Fikret Salık, Meral Erdal Erbatur, Mehmet Ali Turgut, Zülfü Savaş, Ayhan Kaydu, Mehmet Hanifi Okur, Hakkari Aydogdu, Mustafa Azizoglu
Introduction: This prospective, randomized, double-blinded study aimed to compare the incidence of postoperative complications and perioperative analgesic efficacy between caudal and penile block in children undergoing primary hypospadias repair.
Methods: Sixty-two boys aged 6-48 months were randomly assigned to receive either caudal block group (CB, n = 31) or penile block group (PB, n = 31) for preemptive analgesia before surgery. All patients underwent tubularized incised plate urethroplasty. The primary outcome was the incidence of postoperative complications, including urethrocutaneous fistula and meatal stenosis, assessed at 3- and 6-months post-surgery. Secondary outcomes included total perioperative fentanyl consumption and the number of patients requiring rescue analgesia.
Results: There were no significant differences in the incidence of total complications (9.7 % vs. 16.1 %, p = 0.449), fistula (6.5 % vs. 3.2 %, p = 0.554), or meatal stenosis (3.2 % vs. 12.9 %, p = 0.162) between the CB and PB groups. However, fistula rate was significantly higher in patients with midpenil compared to distal hypospadias (13 % vs. 0 %, p = 0.021). Total perioperative fentanyl consumption and the number of patients requiring rescue analgesia were significantly lower in the CB group (p = 0.041 and p = 0.01, respectively).
Conclusion: In conclusion, caudal block provides superior perioperative analgesia without increasing the risk of postoperative complications compared to penile block in children undergoing primary hypospadias repair.
Level of evidence: Level I.
本前瞻性、随机、双盲研究旨在比较行原发性尿道下裂修复术的儿童行尾侧阻滞和阴茎阻滞的术后并发症发生率和围手术期镇痛疗效。方法:将62例6 ~ 48月龄男孩随机分为尾侧阻滞组(CB, n = 31)和阴茎阻滞组(PB, n = 31)进行术前先发制人镇痛。所有患者均行管状切开钢板尿道成形术。主要结果是术后并发症的发生率,包括尿道瘘和金属狭窄,在术后3个月和6个月进行评估。次要结局包括围手术期芬太尼总消耗量和需要急救镇痛的患者人数。结果:CB组与PB组总并发症发生率(9.7% vs. 16.1%, p = 0.449)、瘘管发生率(6.5% vs. 3.2%, p = 0.554)、狭窄发生率(3.2% vs. 12.9%, p = 0.162)差异均无统计学意义。然而,与远端尿道下裂相比,中阴茎组的瘘管发生率明显更高(13% vs. 0%, p = 0.021)。CB组围手术期芬太尼总用量和需要抢救性镇痛的患者数量显著低于对照组(p = 0.041和p = 0.01)。结论:与阴茎阻滞相比,尾侧阻滞在儿童原发性尿道下裂修复术中提供了更好的围术期镇痛,且不增加术后并发症的风险。证据等级:一级。
{"title":"Effects of caudal versus penile block on the incidence of hypospadias complications following primary repairs: A prospective, double-blind, randomized controlled trial.","authors":"Fikret Salık, Meral Erdal Erbatur, Mehmet Ali Turgut, Zülfü Savaş, Ayhan Kaydu, Mehmet Hanifi Okur, Hakkari Aydogdu, Mustafa Azizoglu","doi":"10.1016/j.sempedsurg.2025.151576","DOIUrl":"https://doi.org/10.1016/j.sempedsurg.2025.151576","url":null,"abstract":"<p><strong>Introduction: </strong>This prospective, randomized, double-blinded study aimed to compare the incidence of postoperative complications and perioperative analgesic efficacy between caudal and penile block in children undergoing primary hypospadias repair.</p><p><strong>Methods: </strong>Sixty-two boys aged 6-48 months were randomly assigned to receive either caudal block group (CB, n = 31) or penile block group (PB, n = 31) for preemptive analgesia before surgery. All patients underwent tubularized incised plate urethroplasty. The primary outcome was the incidence of postoperative complications, including urethrocutaneous fistula and meatal stenosis, assessed at 3- and 6-months post-surgery. Secondary outcomes included total perioperative fentanyl consumption and the number of patients requiring rescue analgesia.</p><p><strong>Results: </strong>There were no significant differences in the incidence of total complications (9.7 % vs. 16.1 %, p = 0.449), fistula (6.5 % vs. 3.2 %, p = 0.554), or meatal stenosis (3.2 % vs. 12.9 %, p = 0.162) between the CB and PB groups. However, fistula rate was significantly higher in patients with midpenil compared to distal hypospadias (13 % vs. 0 %, p = 0.021). Total perioperative fentanyl consumption and the number of patients requiring rescue analgesia were significantly lower in the CB group (p = 0.041 and p = 0.01, respectively).</p><p><strong>Conclusion: </strong>In conclusion, caudal block provides superior perioperative analgesia without increasing the risk of postoperative complications compared to penile block in children undergoing primary hypospadias repair.</p><p><strong>Level of evidence: </strong>Level I.</p>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":" ","pages":"151576"},"PeriodicalIF":2.5,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145642328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.sempedsurg.2025.151539
Xiaoyan Liu , Fan Yang , Zhenlei Jia , Ling Zhao , Zaili Chen , Youlei Wei , Fang Yue
Objective
To investigate the risk factors of postoperative poor incision healing in children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure.
Methods
In this study, a retrospective cohort study method was adopted to statistically analyze the clinical data of children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure from 2017 to 2024. The children were categorized into groups with good incision healing and groups with poor healing according to the criteria, and the risk factors that might affect the incision healing were collected, including gender, age, height, weight, BMI, HI, type of pectus excavatum, and previous allergy history, number of the Nuss bars, whether fixation piece was applied, fixation method, suture method, surgical time and bleeding amount.
Results
Based on the inclusion and exclusion criteria, a total of 272 children with Nuss procedure were collected, and during the follow-up period, 25 children experienced poor incision healing. Univariate and multivariate logistic regression analyses were performed in both groups, and the results showed that low BMI, asymmetric pectus excavatum, previous allergy history, wire-fixed bars, and intradermal sutures were independent risk factors for poor incisional healing after the Nuss procedure for pectus excavatum (all P < 0.05).
Conclusion
Poor postoperative incision healing is more likely to occur in children with low BMI, asymmetric pectus excavatum, previous allergy history, and children with intraoperative wire fixation of bars and intradermal sutures.
{"title":"Analysis of risk factors for poor incision healing after the Nuss procedure for pectus excavatum","authors":"Xiaoyan Liu , Fan Yang , Zhenlei Jia , Ling Zhao , Zaili Chen , Youlei Wei , Fang Yue","doi":"10.1016/j.sempedsurg.2025.151539","DOIUrl":"10.1016/j.sempedsurg.2025.151539","url":null,"abstract":"<div><h3>Objective</h3><div>To investigate the risk factors of postoperative poor incision healing in children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure.</div></div><div><h3>Methods</h3><div>In this study, a retrospective cohort study method was adopted to statistically analyze the clinical data of children with congenital pectus excavatum who underwent thoracoscopic-assisted Nuss procedure from 2017 to 2024. The children were categorized into groups with good incision healing and groups with poor healing according to the criteria, and the risk factors that might affect the incision healing were collected, including gender, age, height, weight, BMI, HI, type of pectus excavatum, and previous allergy history, number of the Nuss bars, whether fixation piece was applied, fixation method, suture method, surgical time and bleeding amount.</div></div><div><h3>Results</h3><div>Based on the inclusion and exclusion criteria, a total of 272 children with Nuss procedure were collected, and during the follow-up period, 25 children experienced poor incision healing. Univariate and multivariate logistic regression analyses were performed in both groups, and the results showed that low BMI, asymmetric pectus excavatum, previous allergy history, wire-fixed bars, and intradermal sutures were independent risk factors for poor incisional healing after the Nuss procedure for pectus excavatum (all <em>P</em> < 0.05).</div></div><div><h3>Conclusion</h3><div>Poor postoperative incision healing is more likely to occur in children with low BMI, asymmetric pectus excavatum, previous allergy history, and children with intraoperative wire fixation of bars and intradermal sutures.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151539"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145245739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.sempedsurg.2025.151568
Marcin Polok , Bernarda Kazanowska , Ewa Bień , Aleksandra Karaczewska , Natalia Karkos , Wojciech Apoznański
Background
The aim of the study was an assessment of whether the age of patients with WT could be measured as a risk factor and an analysis of the treatment of patients over 10 years old.
Methods
The data of 942 patients treated because of Wilms tumour from 1997 to 2022 were assessed.
Results
Patients were divided by age into two groups: group 1 (888 (94,27%) patients age 0–9 years old) and group 2 (54 (5,73%) patients age 10–18 years old). In group 1, there were more patients at higher stage than in group 2 (p<0,05). The histology of low risk in group 1 versus group 2 occurred in 13,4% vs 3,7% patients, of intermediate risk in 66,2% vs 66,7% patients and high risk in 19,9% vs 29,6% patients. Results of treatment were assessed only in group 2 which is a limitation of this study. Overall 62,96% patients survived in this group.
Conclusion
Wilms tumour in children 10–18 years old is diagnosed at a higher stage and with worse histology. Overall survival in this age group is lower than in younger children, which is in line with the current literature.
{"title":"Is age in children with Wilms tumour an important prognostic factor?","authors":"Marcin Polok , Bernarda Kazanowska , Ewa Bień , Aleksandra Karaczewska , Natalia Karkos , Wojciech Apoznański","doi":"10.1016/j.sempedsurg.2025.151568","DOIUrl":"10.1016/j.sempedsurg.2025.151568","url":null,"abstract":"<div><h3>Background</h3><div>The aim of the study was an assessment of whether the age of patients with WT could be measured as a risk factor and an analysis of the treatment of patients over 10 years old.</div></div><div><h3>Methods</h3><div>The data of 942 patients treated because of Wilms tumour from 1997 to 2022 were assessed.</div></div><div><h3>Results</h3><div>Patients were divided by age into two groups: group 1 (888 (94,27%) patients age 0–9 years old) and group 2 (54 (5,73%) patients age 10–18 years old). In group 1, there were more patients at higher stage than in group 2 (p<0,05). The histology of low risk in group 1 versus group 2 occurred in 13,4% vs 3,7% patients, of intermediate risk in 66,2% vs 66,7% patients and high risk in 19,9% vs 29,6% patients. Results of treatment were assessed only in group 2 which is a limitation of this study. Overall 62,96% patients survived in this group.</div></div><div><h3>Conclusion</h3><div>Wilms tumour in children 10–18 years old is diagnosed at a higher stage and with worse histology. Overall survival in this age group is lower than in younger children, which is in line with the current literature.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151568"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145427175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.sempedsurg.2025.151565
Ken Chen, Shuhao Zhang, Qingjiang Chen
Background
Pediatric pancreatic pseudocysts are rare clinically and there is no consensus on an optimum treatment strategy for it. Here, we aim to evaluate the outcome and efficacy of percutaneous external drainage in treating pediatric pancreatic pseudocysts.
Methods
All 62 patients with pancreatic pseudocysts from January 2012 to December 2021, were included. Patients were divided into conservative treatment group (Group A) and external drainage group (Group B). A retrospective analysis was performed based on clinical manifestation and prognosis.
Results
The maximum transverse diameter of cysts was significantly smaller in group A than group B (⁎⁎⁎P < 0.001). The duration of cystic regression was significantly greater in group A than group B (⁎⁎P = 0.013). The curative rate (complete disappearance of all pseudocysts) was 73.5% (25/34) in group A and 88.9% (24/27) in group B. The effective treatment rate (complete disappearance of all pseudocysts or persistence of asymptomatic pseudocysts) was 85.3% (29/34) in group A and 92.6% (25/27) in group B. The existence of fibrous septa in the cyst was an independent risk factor for cyst recurrence after external drainage (⁎⁎P = 0.022).
Conclusion
Conservative treatment is feasible for small asymptomatic pseudocysts; external drainage was safe and effective for large and symptomatic pseudocysts, while the presence of fibrous septa in cysts should be carefully evaluated before external drainage surgery.
{"title":"Clinical outcome and risk factors for recurrence of percutaneous external drainage in treating pediatric pancreatic pseudocysts","authors":"Ken Chen, Shuhao Zhang, Qingjiang Chen","doi":"10.1016/j.sempedsurg.2025.151565","DOIUrl":"10.1016/j.sempedsurg.2025.151565","url":null,"abstract":"<div><h3>Background</h3><div>Pediatric pancreatic pseudocysts are rare clinically and there is no consensus on an optimum treatment strategy for it. Here, we aim to evaluate the outcome and efficacy of percutaneous external drainage in treating pediatric pancreatic pseudocysts.</div></div><div><h3>Methods</h3><div>All 62 patients with pancreatic pseudocysts from January 2012 to December 2021, were included. Patients were divided into conservative treatment group (Group A) and external drainage group (Group B). A retrospective analysis was performed based on clinical manifestation and prognosis.</div></div><div><h3>Results</h3><div>The maximum transverse diameter of cysts was significantly smaller in group A than group B (<sup>⁎⁎⁎</sup><em>P</em> < 0.001). The duration of cystic regression was significantly greater in group A than group B (<sup>⁎⁎</sup><em>P</em> = 0.013). The curative rate (complete disappearance of all pseudocysts) was 73.5% (25/34) in group A and 88.9% (24/27) in group B. The effective treatment rate (complete disappearance of all pseudocysts or persistence of asymptomatic pseudocysts) was 85.3% (29/34) in group A and 92.6% (25/27) in group B. The existence of fibrous septa in the cyst was an independent risk factor for cyst recurrence after external drainage (<sup>⁎⁎</sup><em>P</em> = 0.022).</div></div><div><h3>Conclusion</h3><div>Conservative treatment is feasible for small asymptomatic pseudocysts; external drainage was safe and effective for large and symptomatic pseudocysts, while the presence of fibrous septa in cysts should be carefully evaluated before external drainage surgery.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151565"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145373221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01DOI: 10.1016/j.sempedsurg.2025.151564
Mateo Londoño Barrientos , Sofia Pinzon Calderon , Carlos Alberto Lopez Zapata , Carlos Andres Delgado Lopez
Background
Pancreatic trauma in the pediatric population is an uncommon but highly morbid injury. Its management remains controversial, with treatment strategies ranging from non-operative management (NOM) to upfront operative management (OM), primarily guided by the patient's hemodynamic stability and the integrity of the main pancreatic duct. This systematic review and meta-analysis aim to elucidate the comparative effectiveness and safety of NOM versus OM for pediatric pancreatic trauma.
Methods
Following PRISMA guidelines, a systematic search was conducted in seven major databases (including PubMed/MEDLINE, EMBASE, and Scopus) up to September 10, 2025. From 320 identified records, 17 observational studies met the eligibility criteria, comprising 1147 patients. A random-effects meta-analysis was performed to calculate pooled Odds Ratios (OR) with 95% Confidence Intervals (CI) for key outcomes, including mortality, overall complications, pancreatic pseudocyst, and fistula. Bayesian analysis was used for corroboration, and the certainty of evidence was assessed using the GRADE framework.
Results
The analysis found no significant difference between NOM and OM for mortality (OR 0.89; 95% CI 0.48–1.66; I²=0%) or overall complications (OR 0.75; 95% CI 0.41–1.38; I²≈41%). However, a significant clinical trade-off emerged for specific complications. NOM was associated with a significantly higher risk of pancreatic pseudocyst (OR 2.56; 95% CI 1.55–4.23; I²=0%). Conversely, NOM was associated with a substantially lower risk of pancreatic fistula compared to OM (OR 0.27; 95% CI 0.11–0.69; I²=0%). Evidence for other secondary outcomes was largely inconclusive due to statistical imprecision. The certainty of evidence for all outcomes was rated as very low.
Conclusion
Non-operative management is a viable and safe primary strategy in selected pediatric patients with pancreatic trauma and does not appear to increase mortality. The therapeutic decision hinges on a crucial trade-off: NOM increases the risk of pseudocyst formation, while OM increases the risk of iatrogenic fistula. Despite the very low certainty of the available evidence—an inherent limitation of trauma research—these findings provide a critical framework for facilitating shared decision-making. Prospective, multi-center registry studies are urgently needed to establish more definitive guidelines.
背景:胰腺创伤在儿童人群中是一种罕见但高度病态的损伤。其治疗仍然存在争议,治疗策略从非手术治疗(NOM)到术前治疗(OM),主要以患者血流动力学稳定性和主胰管的完整性为指导。本系统综述和荟萃分析旨在阐明NOM与OM治疗儿童胰腺创伤的有效性和安全性的比较。方法:按照PRISMA指南,系统检索截至2025年9月10日的7个主要数据库(包括PubMed/MEDLINE、EMBASE和Scopus)。从320份确定的记录中,17项观察性研究符合资格标准,包括1147名患者。进行随机效应荟萃分析,以95%置信区间(CI)计算关键结局的合并优势比(OR),包括死亡率、总并发症、胰腺假性囊肿和瘘管。使用贝叶斯分析进行确证,并使用GRADE框架评估证据的确定性。结果:分析发现NOM和OM在死亡率(OR 0.89; 95% CI 0.48-1.66; I²=0%)和总并发症(OR 0.75; 95% CI 0.41-1.38; I²≈41%)方面无显著差异。然而,对于特定的并发症,一个重要的临床权衡出现了。NOM与胰腺假性囊肿的风险显著升高相关(OR 2.56; 95% CI 1.55-4.23; I²=0%)。相反,与OM相比,NOM发生胰瘘的风险明显较低(OR 0.27; 95% CI 0.11-0.69; I²=0%)。由于统计不精确,其他次要结果的证据在很大程度上是不确定的。所有结果的证据确定性被评为非常低。结论:对于特定的儿童胰腺创伤患者,非手术治疗是一种可行且安全的主要策略,并且似乎不会增加死亡率。治疗决定取决于一个关键的权衡:NOM增加假性囊肿形成的风险,而OM增加医源性瘘的风险。尽管现有证据的确定性非常低——这是创伤研究的固有局限性——但这些发现为促进共同决策提供了一个关键框架。迫切需要前瞻性、多中心注册研究来建立更明确的指导方针。
{"title":"Systematic review and meta-analysis of the effectiveness and safety of conservative versus surgical management in pediatric pancreatic trauma","authors":"Mateo Londoño Barrientos , Sofia Pinzon Calderon , Carlos Alberto Lopez Zapata , Carlos Andres Delgado Lopez","doi":"10.1016/j.sempedsurg.2025.151564","DOIUrl":"10.1016/j.sempedsurg.2025.151564","url":null,"abstract":"<div><h3>Background</h3><div>Pancreatic trauma in the pediatric population is an uncommon but highly morbid injury. Its management remains controversial, with treatment strategies ranging from non-operative management (NOM) to upfront operative management (OM), primarily guided by the patient's hemodynamic stability and the integrity of the main pancreatic duct. This systematic review and meta-analysis aim to elucidate the comparative effectiveness and safety of NOM versus OM for pediatric pancreatic trauma.</div></div><div><h3>Methods</h3><div>Following PRISMA guidelines, a systematic search was conducted in seven major databases (including PubMed/MEDLINE, EMBASE, and Scopus) up to September 10, 2025. From 320 identified records, 17 observational studies met the eligibility criteria, comprising 1147 patients. A random-effects meta-analysis was performed to calculate pooled Odds Ratios (OR) with 95% Confidence Intervals (CI) for key outcomes, including mortality, overall complications, pancreatic pseudocyst, and fistula. Bayesian analysis was used for corroboration, and the certainty of evidence was assessed using the GRADE framework.</div></div><div><h3>Results</h3><div>The analysis found no significant difference between NOM and OM for mortality (OR 0.89; 95% CI 0.48–1.66; I²=0%) or overall complications (OR 0.75; 95% CI 0.41–1.38; I²≈41%). However, a significant clinical trade-off emerged for specific complications. NOM was associated with a significantly higher risk of pancreatic pseudocyst (OR 2.56; 95% CI 1.55–4.23; I²=0%). Conversely, NOM was associated with a substantially lower risk of pancreatic fistula compared to OM (OR 0.27; 95% CI 0.11–0.69; I²=0%). Evidence for other secondary outcomes was largely inconclusive due to statistical imprecision. The certainty of evidence for all outcomes was rated as very low.</div></div><div><h3>Conclusion</h3><div>Non-operative management is a viable and safe primary strategy in selected pediatric patients with pancreatic trauma and does not appear to increase mortality. The therapeutic decision hinges on a crucial trade-off: NOM increases the risk of pseudocyst formation, while OM increases the risk of iatrogenic fistula. Despite the very low certainty of the available evidence—an inherent limitation of trauma research—these findings provide a critical framework for facilitating shared decision-making. Prospective, multi-center registry studies are urgently needed to establish more definitive guidelines.</div></div>","PeriodicalId":49543,"journal":{"name":"Seminars in Pediatric Surgery","volume":"38 ","pages":"Article 151564"},"PeriodicalIF":2.5,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145394697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}